世界血液学杂志Pub Date : 2023-03-24DOI: 10.5315/wjh.v10.i3.25
Sana Rafaqat, Saira Rafaqat
{"title":"Role of hematological parameters in pathogenesis of diabetes mellitus: A review of the literature","authors":"Sana Rafaqat, Saira Rafaqat","doi":"10.5315/wjh.v10.i3.25","DOIUrl":"https://doi.org/10.5315/wjh.v10.i3.25","url":null,"abstract":"","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42394110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advantageous tactics with certain probiotics for the treatment of graft-versus-host-disease after hematopoietic stem cell transplantation","authors":"Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda","doi":"10.5315/wjh.v10.i2.15","DOIUrl":"https://doi.org/10.5315/wjh.v10.i2.15","url":null,"abstract":"","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44147767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
世界血液学杂志Pub Date : 2022-12-28DOI: 10.5315/wjh.v10.i1.1
B. Jiang, M. Hartzell, Stephen Yu, Muhammad Masab, L. Lyckholm
{"title":"Venous thromboembolism prophylaxis of a patient with MYH-9 related disease and COVID-19 infection: A case report","authors":"B. Jiang, M. Hartzell, Stephen Yu, Muhammad Masab, L. Lyckholm","doi":"10.5315/wjh.v10.i1.1","DOIUrl":"https://doi.org/10.5315/wjh.v10.i1.1","url":null,"abstract":"","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46449850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
世界血液学杂志Pub Date : 2022-12-28DOI: 10.5315/wjh.v10.i1.9
Rupendra Nath Saha, Jayachandran Selvaraj, S. Viswanathan, V. Pillai
{"title":"Typhoid with pancytopenia: Revisiting a forgotten foe: Two case reports","authors":"Rupendra Nath Saha, Jayachandran Selvaraj, S. Viswanathan, V. Pillai","doi":"10.5315/wjh.v10.i1.9","DOIUrl":"https://doi.org/10.5315/wjh.v10.i1.9","url":null,"abstract":"","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48841702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
世界血液学杂志Pub Date : 2022-07-29DOI: 10.5315/wjh.v9.i3.20
Jamile Silva Lopes, Ícaro Garcia Viana, Maria Luísa Cordeiro Santos, Fabrício Freire de Melo, M. V. Oliveira, C. L. Souza
{"title":"Cardiopulmonary changes in patients with sickle cell anemia: A systematic review","authors":"Jamile Silva Lopes, Ícaro Garcia Viana, Maria Luísa Cordeiro Santos, Fabrício Freire de Melo, M. V. Oliveira, C. L. Souza","doi":"10.5315/wjh.v9.i3.20","DOIUrl":"https://doi.org/10.5315/wjh.v9.i3.20","url":null,"abstract":"BACKGROUND Given the high prevalence of cardiovascular and pulmonary abnormalities associated with sickle cell anemia (SCA), the clinical impact caused in addition to compromising the quality of life of patients and the overcharge that it represents to the public health system, this study systematized and evaluated scientific publications on pulmonary complications and cardiovascular diseases in sickle cell patients from 1920 to 2020. This compilation aims to provide knowledge for health professionals and managers in order to draw attention to the importance of chronic diseases in SCA patients and in addition to providing elements that provide improvements in management of useful resources that contribute to improve the quality and increase the life expectancy of these patients. AIM To systematically compile information about cardiopulmonary changes in patients with SCA. METHODS A systematic literature review was performed based on the PRISMA recommendation including scientific articles indexed in the Scientific Electronic Library Online databases of the United States National Library of Medicine and Biblioteca Virtual de Saúde. The search period was delimited between 1990 and 2020 and selected in Portuguese, English and Spanish. Three sets of descriptors were used for each database including research carried out with human beings. After reading the articles, those useful for this review were extracted using a collection instrument designed for this purpose. RESULTS The final selection included 27 studies. The year with the highest number of Silva Lopes J et al. Cardiopulmonary changes in SCA WJH https://www.wjgnet.com 21 July 29, 2022 Volume 9 Issue 3 publications was 2016 with 5 studies (18.51%), followed by 2017 with 4 (14.81%). The type of study most carried out in the period was cohort 10 (37.03%) followed by cross-sectional and case-control with 8 studies in each (29.62%). Regarding the language of publication, the distribution was as follows: 25 (92.59%) in English, 1 (3.70%) in Spanish and 1 (3.70%) in Portuguese. CONCLUSION The findings of the present study suggest that cardiopulmonary alterations represent a serious clinical repercussion of SCA. Of the analyzed studies, the high occurrence of pulmonary hypertension, ventricular hypertrophy and diastolic dysfunction stands out as the main cardiopulmonary complications. In view of the increased survival in SCA, there is a need for surveillance and the development of strategies aimed at preserving the cardiopulmonary function and consequently improving the quality of life of these patients.","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46917574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
世界血液学杂志Pub Date : 2022-04-25DOI: 10.5315/wjh.v9.i2.13
Kristen Jane Kilby, Catherine Anderson-Quiñones, Keith R. Pierce, Kirollos Gabrah, Ankur Seth, Allison Brunson
{"title":"Late ischemic stroke and brachiocephalic thrombus in a 65-year-old patient six months after COVID-19 infection: A case report","authors":"Kristen Jane Kilby, Catherine Anderson-Quiñones, Keith R. Pierce, Kirollos Gabrah, Ankur Seth, Allison Brunson","doi":"10.5315/wjh.v9.i2.13","DOIUrl":"https://doi.org/10.5315/wjh.v9.i2.13","url":null,"abstract":"BACKGROUND Although it is well established that coronavirus disease 2019 (COVID-19) is associated with inflammation and a prothrombotic state leading to stroke and venous thromboembolism (VTE), the nuances of this association are yet to be uncovered[1]. Many studies link elevations in inflammatory markers to cases of thromboembolism. Most reports of thromboembolism associated with COVID-19 occur in the venous circulation during or just after the initial hospitalization due to COVID-19[2]. It is unclear how long the hypercoagulable effect of COVID-19 lasts. CASE SUMMARY We present a unique case of a 65-year-old-female who presented to her primary care doctor with a sore throat, cough, fatigue, congestion, diarrhea, headache, and anosmia. She tested positive for severe acute respiratory syndrome coronavirus 2 and received a bamlanivimab infusion 9 days later. After recovering from the acute illness, she received the Pfizer-BioNTech COVID-19 vaccine. Months later, she presented to the Emergency Department (ED) complaining of right sided shoulder pain and motor weakness in her left hand while trying to type on a keyboard. On presentation to the ED, her calculated Padua prediction score for risk of VTE was two and inflammatory markers were not elevated. She was found to have a brachiocephalic artery occlusion as well as an ischemic stroke which was treated with heparin. CONCLUSION Kilby KJ et al. Late Hypercoagulability in COVID-19 WJH https://www.wjgnet.com 14 April 25, 2022 Volume 9 Issue 2 This case suggests hypercoagulability due to COVID-19 may extend further than current literature suggests, to at least six months.","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48427730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
世界血液学杂志Pub Date : 2022-02-25DOI: 10.5315/wjh.v9.i1.6
Qian Gao, Xiaowei Xin, Chunli Zhao, Yujuan Wang, Wei Wang, Yi Yin, Xiaoru Wang, You-peng Jin
{"title":"Efficacy of HA330-II column hemoadsorption in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis combined with liver failure: A case report","authors":"Qian Gao, Xiaowei Xin, Chunli Zhao, Yujuan Wang, Wei Wang, Yi Yin, Xiaoru Wang, You-peng Jin","doi":"10.5315/wjh.v9.i1.6","DOIUrl":"https://doi.org/10.5315/wjh.v9.i1.6","url":null,"abstract":"Abstract BACKGROUND Hemophagocytic lymphohistiocytosis (HLH) is a severe and potentially deadly condition associated with extensive inflammation and immune activation. Cytokine adsorption may serve as a supportive treatment that can stabilize organ function in affected patients by reducing their circulating cytokines levels. To date, no descriptions of clinical experiences associated with the use of HA330-II column hemoadsorption for the treatment of HLH children have been published. CASE SUMMARY We describe a 11-year-old children with Epstein-Barr virus (EBV)-associated HLH combined with liver failure. She underwent HA330-II column hemoadsorption and chemotherapy, and developed a decreased inflammatory cytokines including interleukin (IL)-6, IL-8, IL-10, and interferon (IFN)-γ. The patient’ condition and laboratory parameters gradually improved. CONCLUSION Hemoadsorption may play an important role in eliminating cytokines storm in children with Hemophagocytic lymphohistiocytosis combined with liver failure and consequent multiple organ failure.","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42914328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
世界血液学杂志Pub Date : 2022-02-25DOI: 10.5315/wjh.v9.i1.1
Haroon Nawaz, Ayesha A. Choudhry, William Morse
{"title":"Central nervous system recurrence in a patient treated for acute promyelocytic leukemia, resulting in sideroblastic anemia: A case report","authors":"Haroon Nawaz, Ayesha A. Choudhry, William Morse","doi":"10.5315/wjh.v9.i1.1","DOIUrl":"https://doi.org/10.5315/wjh.v9.i1.1","url":null,"abstract":"BACKGROUND Previous cases that have been stated in this article have displayed that around 1% to 7% of patients that have been treated with chemotherapy for acute promyelocytic leukemia developed myelodysplastic syndrome or acute myeloid leukemia. One can see that’s why this case presentation of a 60-year-old man that had a good response to acute promyelocytic leukemia treatment, that later presented with a central nervous system recurrence of acute promyelocytic leukemia and acquired sideroblastic anemia (a form of myelodysplasia) from treatment is a unique case report. CASE SUMMARY The presence of central nervous system relapse in acute promyelocytic leukemia patients is very unlikely compared to recurring mainly in the bone marrow. It is also uncommon to be diagnosed with sideroblastic anemia (form of myelodysplastic syndrome) as a result from treatment for acute promyelocytic leukemia. This case report highlights the detection, treatment/maintenance with idarubicin, all-trans-retinoic-acid, arsenic trioxide, methotrexate, 6-mercaptopurine, and ommaya reservoir intrathecal methotrexate administration in a patient that had central nervous system relapse of acute promyelocytic leukemia and acquired sideroblastic anemia. CONCLUSION In essence, first time relapse concerning the central nervous system in treated Nawaz H et al. Acute promyelocytic leukemia treatment resulting in sideroblastic anemia WJH https://www.wjgnet.com 2 February 25, 2022 Volume 9 Issue 1 acute promyelocytic leukemia patients who had a good response to therapy is very uncommon. The acquirement of a myelodysplastic syndrome such as ringed sideroblastic anemia is also rare regarding this patient population. Although such cases are infrequent, this case report represents a unique insight of the detection, treatment, and maintenance of a 60-year-old man diagnosed with acute promyelocytic leukemia, resulting in the acquirement of sideroblastic anemia and central nervous system relapse.","PeriodicalId":60524,"journal":{"name":"世界血液学杂志","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49254736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}